These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 5482538)
41. [Organization and results of screening for phenylketonuria in the Slovak Socialist Republic in 1972-1978 (author's transl)]. Varga F Cas Lek Cesk; 1979 Nov; 118(43-44):1327-30. PubMed ID: 519689 [No Abstract] [Full Text] [Related]
42. Hyperphenylalaninemia in the Philippines. Capistrano-Estrada S; Padilla CD Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():182-4. PubMed ID: 15906731 [TBL] [Abstract][Full Text] [Related]
43. [Report of the Commission de l'Hygiène de l'Enfance on the danger respresented by phenylketonuria as a cause of mental retardation and on the necessity of early detection of thisdisease]. Lamy M Bull Acad Natl Med; 1968 Feb; 152(5):76-8. PubMed ID: 4920129 [No Abstract] [Full Text] [Related]
44. Phenylketonuria in school age retarded children. Williamson M; Koch R; Henderson R Am J Ment Defic; 1968 Mar; 72(5):740-7. PubMed ID: 5646276 [No Abstract] [Full Text] [Related]
46. A review of the program for the detection of genetic diseases in the public health laboratory. Atkins R; Tomlin G J Med Assoc State Ala; 1971 Mar; 40(9):613-4 passim. PubMed ID: 5549105 [No Abstract] [Full Text] [Related]
47. [Systematic neonatal screening. Status and organization. Apropos of the French experience]. Farriaux JP LARC Med; 1982 Dec; 2(11):963-7. PubMed ID: 7162262 [No Abstract] [Full Text] [Related]
49. The results of routine screening for phenylketonuria and galactosaemia in mentally retarded children. Amla I; Punekar BD Indian Pediatr; 1968 May; 5(5):209-17. PubMed ID: 5681616 [No Abstract] [Full Text] [Related]
50. Adverse medical outcomes of early newborn screening programs for phenylketonuria. Brosco JP; Sanders LM; Seider MI; Dunn AC Pediatrics; 2008 Jul; 122(1):192-7. PubMed ID: 18596006 [TBL] [Abstract][Full Text] [Related]
51. Newborn screening for phenylketonuria: incidence and screening procedures in North America. Somers DG; Favreau L Can J Public Health; 1982; 73(3):206-7. PubMed ID: 7127244 [No Abstract] [Full Text] [Related]
52. [Neonatal screening for metabolic diseases--a task without priority in the Norwegian health policy?]. Pettersen RD; Saugstad OD; Lie SO Tidsskr Nor Laegeforen; 1995 Feb; 115(5):607-8. PubMed ID: 7900116 [TBL] [Abstract][Full Text] [Related]
53. [Guthrie's test in the detection of phenylketonuria. Its realization in Gironde, its psychological and practical difficulties]. Marc Y Rev Fr Gynecol Obstet; 1970; 65(1):29-31. PubMed ID: 5439208 [No Abstract] [Full Text] [Related]
54. [Molecular pathology and DNA diagnosis of phenylketonuria and hypermethioninemia]. Nagao M Tanpakushitsu Kakusan Koso; 1998 May; 43(6):762-9. PubMed ID: 9612070 [No Abstract] [Full Text] [Related]
55. [Early detection of aminoacidopathies, with special reference the screening program for phenylketonuria in the region of Liguria]. Romano C; Grossi-Bianchi ML; Sietti C; Ferretti G; Auxilia F; Falciola N Minerva Nipiol; 1970; 20(5):144-55. PubMed ID: 5566888 [No Abstract] [Full Text] [Related]
56. [Neonatal detection of phenylketonuria and hypothyroidism. Realities and perspectives]. Farriaux JP An Esp Pediatr; 1988 Sep; 29 Suppl 32():272-9. PubMed ID: 3150256 [No Abstract] [Full Text] [Related]
57. [Value of neonatal diagnosis of phenylketonuria]. Lambotte C Rev Med Liege; 1975 Feb; 30(3):86-7. PubMed ID: 1162212 [No Abstract] [Full Text] [Related]